UBIO
Proshares UltraPro NASDAQ Biotechnology
UBIO
UBIO
Delisted
UBIO was delisted on the 27th of March, 2020.
7 hedge funds and large institutions have $3.18M invested in Proshares UltraPro NASDAQ Biotechnology in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
2
Closed
3
Calls
$1.04M
Puts
$834K
Net Calls
+$203K
Net Calls Change
-$379K
Top Buyers
1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$677K |
2 |
VF
Virtu Financial
New York
|
+$632K |
3 |
Jane Street
New York
|
+$276K |
4 |
Citadel Advisors
Miami,
Florida
|
+$212K |
5 |
Morgan Stanley
New York
|
+$13K |
Top Sellers
1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$757K |
2 |
UBS Group
Zurich,
Switzerland
|
-$104K |
3 |
Creative Planning
Overland Park,
Kansas
|
-$5K |
4 |
![]()
Simplex Trading
Chicago,
Illinois
|
-$2K |